CLINICAL TRIALS PROFILE FOR EPINEPHRINE BITARTRATE
✉ Email this page to a colleague
All Clinical Trials for EPINEPHRINE BITARTRATE
Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
---|---|---|---|---|---|---|
NCT02353676 ↗ | Bupivacaine Supplementation For Postoperative Pain Control In Surgical Removal Of Mandibular Third Molars | Unknown status | Cosmozone Dental Clinic | N/A | 2015-01-01 | Control of postoperative pain is a foremost goal in achieving a satisfactory postoperative recovery. Surgical removal of lower third molars is accompanied by postoperative pain that is at its peak in the first 12 hours. Our study evaluates if the use of 2% lidocaine hydrochloride for the surgical removal of lower third molars with a postoperative 0.5% bupivacaine supplementation would result in lesser postoperative pain and a decrease in ingestion of oral analgesics to control the pain when compared to a placebo. |
NCT03672500 ↗ | Perineal Local Infiltration Study | Recruiting | Sunnybrook Health Sciences Centre | N/A | 2018-09-14 | The prevalence of birth canal lacerations is more than 70% of all deliveries in Canada. The repair of such lacerations is usually done using a pre-existing epidural analgesia. Once the analgesic effect of the epidural analgesia fades, the laceration may cause intolerable pain, and result in emotional stress, difficulties in ambulation and breastfeeding, and more. The research team hypothesis is that adding a locally injected analgesic, which will take effect once the epidural analgesia fades, may alleviate perineal pain, prevent such difficulties, and improve women's overall well-being and satisfaction. The proposed trial is a two-arm, single-masked, randomized trial. Women with a working epidural analgesia, and a laceration will be invited to participate. Women in the local anesthesia (LA) arm will get a LA injected to the laceration and women in the sham arm will get no injection. The differences in perineal pain between the groups will be evaluated at 6 hours after last epidural dose. |
NCT05152901 ↗ | Study of Inhaled Epinephrine and Intramuscular Epinephrine Administered to Healthy Adults | Not yet recruiting | Novotech (Australia) Pty Limited | Phase 1 | 2022-01-23 | This is a study to determine the relative bioavailability of inhaled epinephrine compared with 0.3mg epinephrine administered IM in healthy male and female participants. |
>Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for EPINEPHRINE BITARTRATE
Condition Name
Clinical Trial Locations for EPINEPHRINE BITARTRATE
Clinical Trial Progress for EPINEPHRINE BITARTRATE
Clinical Trial Phase
Clinical Trial Sponsors for EPINEPHRINE BITARTRATE
Sponsor Name